Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Farmson is a leading global manufacturer of Active Pharmaceutical Ingredients (APIs), specializing primarily in Paracetamol (Acetaminophen). Established in 1970 and headquartered in Vadodara, India, the company operates multiple state-of-the-art manufacturing facilities that adhere to international quality standards such as WHO-GMP and USFDA. Farmson is recognized as one of the world's largest producers of Paracetamol, offering various grades including powder, crystals, and DC (Direct Compression) granules. In addition to its flagship product, the company manufactures other APIs like Guaifenesin and Methocarbamol, serving a diverse global clientele in the pharmaceutical industry. The company is notable for being the first to commercially produce Paracetamol via the Nitrobenzene route.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Farmson.